Allogeneic stem cell transplantation with matched sibling donor versus autologous stem cell transplantation for newly diagnosed Multiple Myeloma
Editorial Group: Cochrane Haematological Malignancies Group
Published Online: 30 APR 2013
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Tan Y, Xu S, Li X, Chen J. Allogeneic stem cell transplantation with matched sibling donor versus autologous stem cell transplantation for newly diagnosed Multiple Myeloma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010484. DOI: 10.1002/14651858.CD010484.
- Publication Status: New
- Published Online: 30 APR 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
To compare the effects of the use of autologous stem cell transplantation (ASCT), which includes single ASCT and tandem ASCT, versus allogeneic stem cell transplantation (alloSCT) from a matched sibling donor, which includes single alloSCT, non-myeloablative alloSCT and ASCT-alloSCT, in patients with multiple myeloma (MM).